3.705-南京医科大学.doc

南京医科大学破格、拔尖申报高级职务科研能力测定一览表 姓　　　名 顾艳宏 所在学院 第一临床学院 学历学位 研究生、博士 现　职　称 主任医师、副教授 现职时间 2010年9月 申报职称 教授 一、出版物 1．论文 题　　　　　目 刊物名称及发表时间 排名 是否SCI收录 SCI影响因子 分值 Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer Autophagy 2014 共同通讯作者 是 11.753 Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3 beta/beta-Catenin Pathway NEOPLASIA 2015 共同通讯作者 是 4.252 CPT-11?activates?NLRP3?inflammasome?through?JNK?and NF-κB?signalings Toxicology and Applied Pharmacology 2015 共同通讯作者 是 3.705 Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer Biomed Pharmacother 2014 共同通讯作者 是 2.023 Erlotinib promotes endoplasmic reticulum stress-mediated injury in the intestinal epithelium Toxicology and Applied Pharmacology 2014 共同通讯作者 是 3.705 Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation Biomed Pharmacother 2014 共同通讯作者 是 2.023 EGFR inhibitor-driven endoplasmic reticulum stress-mediated injury on intestinal epithelial cells Life Sci 2014 共同第一作者 是 2.702 Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity Anticancer Drugs 2014 通讯作者 是 1.784 Beauvericin Ameliorates Experimental Colitis by Inhibiting Activated T Cells via Downregulation of the PI3K/Akt Signaling Pathway PLOS ONE 2013 第七作者 是 3.534 Xiao-Ai-Ping, a TCM Injection, Enhances the Antigrowth Effects of Cisplatin on Lewis Lung Cancer Cells through Promoting the Infiltration and Function of CD8(+) T Lymphocytes Evid Based Complement Alternat Med 2013 共同通讯作者 是 2.175 Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling Biomed Pharmacother 2013